Skip to content
SPACListing
Liquidated

Stem Sales, Inc.

CIK 0001614083

Cash in trust

—

Not yet disclosed

Trust per share

—

Redemption value

IPO

—

—

Combination deadline

—

Not disclosed

Filings on record

36

Latest Nov 9, 2017

Overview

Stem Sales, Inc. is a special purpose acquisition company incorporated in Florida and registered with the SEC under CIK 0001614083. The vehicle is sponsored by Stem Sales. Deadline lapsed without a deal; trust returned to public shareholders.

How busy it has been

Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.

5302014-082017-11

36 filings in all. 1 in the last three months, against a busiest month of 5.

News on Stem Sales, Inc.

Last 90 days

Nothing in the last 90 days that names this vehicle. We attribute a story only when the release carries the ticker or the registered name, so an empty section means no press release or wire story matched — not that nothing was published. The filings below are the primary record either way.

SEC filing history

Free tier: filings older than 24 hours
  • 10-Q

    Quarterly report

    Accession 0001173375-17-000071

    Nov 9, 2017

    9y ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001173375-17-000058

    Aug 2, 2017

    9y ago

    View on EDGAR ↗
  • 424B3

    Prospectus supplement

    Accession 0001173375-17-000047

    May 24, 2017

    9y ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001173375-17-000037

    May 11, 2017

    9y ago

    View on EDGAR ↗
  • 10-K

    Annual report

    Accession 0001173375-17-000016

    Feb 15, 2017

    9y ago

    View on EDGAR ↗
  • 424B3

    Prospectus supplement

    Accession 0001173375-17-000006

    Jan 17, 2017

    9y ago

    View on EDGAR ↗
  • 8-K

    Other events

    Item 8.01 · Accession 0001173375-16-000315

    Dec 27, 2016

    9y ago

    View on EDGAR ↗
  • 8-K

    Other events

    Item 8.01 · Accession 0001173375-16-000309

    Dec 13, 2016

    9y ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001173375-16-000278

    Nov 4, 2016

    10y ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001173375-16-000252

    Aug 11, 2016

    10y ago

    View on EDGAR ↗
  • 424B3

    Prospectus supplement

    Accession 0001173375-16-000250

    Aug 9, 2016

    10y ago

    View on EDGAR ↗
  • 10-Q/A

    10-Q/A filing

    Accession 0001173375-16-000202

    May 10, 2016

    10y ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001173375-16-000199

    May 10, 2016

    10y ago

    View on EDGAR ↗
  • 10-K

    Annual report

    Accession 0001173375-16-000154

    Feb 16, 2016

    10y ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001173375-15-000118

    Oct 28, 2015

    11y ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001173375-15-000084

    Aug 4, 2015

    11y ago

    View on EDGAR ↗
  • 8-K

    Current report

    Items 4.01, 9.01 · Accession 0001173375-15-000074

    Jun 30, 2015

    11y ago

    View on EDGAR ↗
  • 10-Q

    Quarterly report

    Accession 0001173375-15-000060

    May 12, 2015

    11y ago

    View on EDGAR ↗
  • 10-K

    Annual report

    Accession 0001173375-15-000043

    Apr 6, 2015

    11y ago

    View on EDGAR ↗
  • EFFECT

    Notice of effectiveness

    Accession 9999999995-15-000272

    Feb 3, 2015

    11y ago

    View on EDGAR ↗
  • CORRESP

    Correspondence with SEC staff

    Accession 0001614083-15-000005

    Jan 29, 2015

    11y ago

    View on EDGAR ↗
  • S-1/A

    Amended IPO registration statement

    Accession 0001173375-15-000016

    Jan 26, 2015

    11y ago

    View on EDGAR ↗
  • S-1/A

    Amended IPO registration statement

    Accession 0001614083-15-000003

    Jan 20, 2015

    11y ago

    View on EDGAR ↗
  • UPLOAD

    SEC staff comment letter

    Accession 0000000000-15-002040

    Jan 15, 2015

    11y ago

    View on EDGAR ↗
  • S-1/A

    Amended IPO registration statement

    Accession 0001173375-15-000002

    Jan 5, 2015

    11y ago

    View on EDGAR ↗
  • UPLOAD

    SEC staff comment letter

    Accession 0000000000-14-065602

    Dec 18, 2014

    12y ago

    View on EDGAR ↗
  • S-1/A

    Amended IPO registration statement

    Accession 0001173375-14-000311

    Dec 8, 2014

    12y ago

    View on EDGAR ↗
  • UPLOAD

    SEC staff comment letter

    Accession 0000000000-14-055997

    Nov 10, 2014

    12y ago

    View on EDGAR ↗
  • S-1/A

    Amended IPO registration statement

    Accession 0001173375-14-000270

    Oct 20, 2014

    12y ago

    View on EDGAR ↗
  • UPLOAD

    SEC staff comment letter

    Accession 0000000000-14-051261

    Oct 14, 2014

    12y ago

    View on EDGAR ↗

Pro

Track Stem Sales, Inc. without the delay

Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.

  • Filings live, no 24-hour delay
  • One click through to the source document
  • Deadline calendar out to 12 months
  • CSV export, API and MCP access

Cancel any time. Billed monthly in USD.

Stem Sales, Inc.: questions answered

What is Stem Sales, Inc.?

Stem Sales, Inc. is a special purpose acquisition company incorporated in Florida and registered with the SEC under CIK 0001614083. The vehicle is sponsored by Stem Sales. Deadline lapsed without a deal; trust returned to public shareholders.

How much does Stem Sales, Inc. hold in trust?

No trust balance has been disclosed in a filing we have indexed for Stem Sales, Inc.. For a newly priced IPO this is normal: the figure first appears in the quarterly report after closing.

When must Stem Sales, Inc. complete a merger?

No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.

What happens if Stem Sales, Inc. does not find a target in time?

The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.

Can I redeem shares in Stem Sales, Inc., and at what price?

Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.

Is the trust value the same as the share price for Stem Sales, Inc.?

No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.

Who sponsors Stem Sales, Inc., and what is their track record?

Stem Sales is the sponsor entity, part of the Stem Sales franchise. This is the only vehicle we have attributed to that sponsor.

Is Stem Sales, Inc. a good investment?

That is not a question this site answers. Stem Sales, Inc. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.

Where does this Stem Sales, Inc. data come from?

Filings Stem Sales, Inc. submitted to the SEC under CIK 0001614083: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.

Compiled by the SPACListing research desk

Last reconciled Oct 19, 2026

Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.

Read the full methodology · What is in the dataset · Report a correction

SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.

Continue reading

The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.